Sustaining healthy, profitable, branded growth
H1 and Q2 2017 highlights
Reported revenue growth of 14.0% for H1 (Q2: 12.7%)
Own brands autonomous growth of 7.8% in H1 (Q2: 6.5%)
EBITE increases by 22.4% to €30.6 million for H1 (Q2: €11.6 million)
CEO Statement
Christophe Barnouin (CEO) commented: "We have managed to sustain healthy profitable growth throughout the first half of 2017. Many of our own brands are growing at strong double-digit levels in H1 while the Private Label and Distribution brands have declined by close to 20% in line with our strategy.

The turn-around of our Germany business is on track, on the back of extended listings in the Grocery channel (especially drug stores) and successful restructuring activities.

Integration of our acquisitions from 2016 is progressing well and key operations projects are delivering fuel to re-invest into the growth of our brands.

Profitability of our business has further increased and EBITE is up 22.4% delivering an EBITE margin of 9.4%.

For the first time ever we have run a program for Organic Start ups ("Organic Food against Climate Change") in cooperation with Triodos Bank in order to support change in the Food market beyond our own business.

We remain confident that 2017 will be yet another year of healthy, sustainable and profitable growth for Wessanen."

There will also be a live audio webcast via www.wessanen.com

tijd 09.35
De Midcap 807,01 +0,26 +0,03% Wessanen EUR 13,72 -48ct vol. 199.000 te hoge verwachtingen, maar Wessanen heeft haar strategie juist en is een overname kandidaat.

tijd 11.34
De Midcap 804,15 -2,58 -0,32% Wessanen EUR 14,13 -7ct vol. 391.000

tijd 15.28
Wessanen EUR 14,365 +16,5ct vol. 616.550
Beleggers realiseren de werkelijkheid NU pas, blijft zitten waar je zit, want gezond eten voldoet aan twee kanten, je gezondheid blijft optimaal en je leeft plezieriger en met minder ongemakken.